Expert Rev Ophthalmol. 2013;8(5):475-484. Together, these preclinical data indicate that both antibody and small kinase-based VEGF/PDGF antagonists are effective in animal models of pathologic ocular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback